跳至主要内容
临床试验/IRCT2013100114847N1
IRCT2013100114847N1已完成未知

Sustained release of micro- spherical minocycline for management of peri-implant mucosal inflammation

Vice Chancellor for research of Tabriz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • 1) Adults aged 18 or over with at least one implant in function for more than one year
  • 2) Mild peri-imlant inflammatory diseases. defined as: presence of Bleeding on Probing, radio-graphic bon loss at the site of the implant less than 2 mm and probing depth more than 4 mm
  • Exclusion criteria:
  • 1) Any related systemic diseases
  • 2) Smoking
  • 3) Pregnancy and lactation
  • 4) Active periodontal disease
  • 5) Consumption of systemic antibiotics in the late 3 months
  • 6) Need for bacterial prophylaxis with systemic antibiotics
  • 7) Long-term use of any drug affects periodontal tissue conditions
  • 8) Probing depth greater than 6 mm at base line visit
  • 9) Drug and alcohol abuse
  • 10) Uncontrolled diabetes
  • 11) Probing depth less than 4 mm at base line visit

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for research of Tabriz University of Medical Sciences

相似试验

ocal antibiotic therapy in peri- implant inflammatio | 临床试验